Global Trust Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6K | Sell |
60
-62
| -51% | -$20.2K | 0.01% | 335 |
|
|
2025
Q1 | $32.9K | Hold |
122
| – | – | 0.02% | 275 |
|
|
2024
Q4 | $28.7K | Hold |
122
| – | – | 0.01% | 330 |
|
|
2024
Q3 | $33.6K | Hold |
122
| – | – | 0.01% | 309 |
|
|
2024
Q2 | $29.6K | Hold |
122
| – | – | 0.01% | 294 |
|
|
2024
Q1 | $18.2K | Hold |
122
| – | – | 0.01% | 324 |
|
|
2023
Q4 | $23.4K | Hold |
122
| – | – | 0.01% | 291 |
|
|
2023
Q3 | $21.6K | Hold |
122
| – | – | 0.01% | 289 |
|
|
2023
Q2 | $23.2K | Hold |
122
| – | – | 0.01% | 285 |
|
|
2023
Q1 | $24.4K | Hold |
122
| – | – | 0.01% | 266 |
|
|
2022
Q4 | $29K | Hold |
122
| – | – | 0.01% | 248 |
|
|
2022
Q3 | $24K | Hold |
122
| – | – | 0.01% | 263 |
|
|
2022
Q2 | $18K | Hold |
122
| – | – | 0.01% | 287 |
|
|
2022
Q1 | $20K | Hold |
122
| – | – | 0.01% | 332 |
|
|
2021
Q4 | $21K | Sell |
122
-13
| -10% | -$2.24K | 0.01% | 311 |
|
|
2021
Q3 | $25K | Hold |
135
| – | – | 0.01% | 277 |
|
|
2021
Q2 | $23K | Hold |
135
| – | – | 0.01% | 284 |
|
|
2021
Q1 | $19K | Buy |
+135
| New | +$19K | 0.01% | 262 |
|